Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1064211]Researchers: Dr Mark Guthridge (Principal investigator)
Brief description While most leukemia patients initially respond well to chemotherapy, >70% die because the disease returns as a result of the survival of leukaemia cells following treatment. We seek to block the switch mechanisms within leukemic cells that allow them to survive current drug therapies. We now seek to examine the therapeutic potential of our discovery with a view toward developing new targetted therapies in the future.
Funding Amount $AUD 631,010.39
Funding Scheme Research Fellowships
Notes Research Fellowship
- nhmrc : 1064211
- PURL : https://purl.org/au-research/grants/nhmrc/1064211
